You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intermediate syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dravet Syndrome, Lennox Gastaut Syndrome, Developmental and Epileptic Encephalopathies Trial run by the Longboard

Available
  • Dravet Syndrome
  • +2 more
  • Bethesda, Maryland
    Mid-Atlantic Epilepsy and Sleep Center
Nov 19, 2023

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Post COVID-19 Syndrome Trial in Sugar Land (HB-adMSCs)

No longer available
  • Post COVID-19 Syndrome
  • HB-adMSCs
  • Sugar Land, Texas
    Hope Biosciences Stem Cell Research Foundation
Nov 1, 2022

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

Chest Pain, Acute Coronary Syndrome, Coronary Artery Disease Trial in Stockholm (Coronary computed tomopraphic angiography)

Recruiting
  • Chest Pain
  • +2 more
  • Coronary computed tomopraphic angiography
  • Stockholm, Sweden
    Danderyd Hospital
Aug 16, 2022

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) Trial (Remestemcel-L,

Available
  • Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
  • Remestemcel-L
  • +2 more
  • (no location specified)
Apr 12, 2022

MDS Trial in Miami, New York (50 gm CIVI/24 hours x 5 days every 4 week)

Recruiting
  • Myelodysplastic Syndromes
  • 50 gm CIVI/24 hours x 5 days every 4 week
  • Miami, Florida
  • +1 more
Jul 6, 2022

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

Common Bile Duct Injury Trial (Intermediate repair, Delayed repair)

Completed
  • Common Bile Duct Injury
  • Intermediate repair
  • Delayed repair
  • (no location specified)
Jun 28, 2022

KCNJ11-related Intermediate Developmental Delay, Epilepsy and

Recruiting
  • Neurodevelopmental Disorders
  • +5 more
  • Chicago, Illinois
  • +3 more
Feb 20, 2023

Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Trial (Triheptanoin)

Available
  • Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
  • (no location specified)
Nov 22, 2022

Traumatic Brain Injury, Acute Respiratory Failure, Acute Respiratory Distress Syndrome Trial in Athens (Oxygen)

Not yet recruiting
  • Traumatic Brain Injury
  • +3 more
  • Oxygen
  • Athens, Greece
  • +1 more
Jul 25, 2022

CT-FFR Compared to CCTA or CCTA and Stress MPI in Low to

Enrolling by invitation
  • Coronary Artery Disease
  • +3 more
  • Toshiba CT-FFR
  • Manhasset, New York
    North Shore University Hospital
Oct 25, 2022

High Risk Myelodysplastic Syndrome, IPSS Risk Category Intermediate-1, Myelodysplastic Syndrome Trial in Houston (Azacitidine,

Active, not recruiting
Has Results
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Mitochondrial Diseases, Barth Syndrome Trial (elamipretide)

Available
  • Mitochondrial Diseases
  • Barth Syndrome
  • (no location specified)
Nov 1, 2021

Coronary Calcification Detection on CT Scan

Recruiting
  • Acute Coronary Syndrome
    • Strasbourg, France
      Service d'accueil des urgences - CHU de Strasbourg - France
    Sep 8, 2022

    Multiple System Atrophy (MSA) Trial in Morrisville (BHV3241, verdiperstat)

    No longer available
    • Multiple System Atrophy (MSA)
    • BHV3241, verdiperstat
    • Morrisville, North Carolina
      PPD
    Oct 4, 2022

    Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

    Completed
    • Anemia in Myelodysplastic Syndromes
    • Plantation, Florida
    • +2 more
    Apr 4, 2022

    Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

    Active, not recruiting
    Has Results
    • Myelodysplastic Syndrome
    • Revlimid (Lenalidomide)
    • New York, New York
      Columbia University Medical Center
    Jan 12, 2022

    Concussion, Mild, Concussion, Brain, Concussion, Severe Trial in Indianapolis (Treatment)

    Recruiting
    • Concussion, Mild
    • +7 more
    • Treatment
    • Indianapolis, Indiana
      Indiana University
    Jan 5, 2023

    MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Saint Louis, Missouri
    • +20 more
    Dec 28, 2022

    MDS Trial in Bronx (Pyrimethamine)

    Withdrawn
    • Myelodysplastic Syndromes
    • Bronx, New York
      Montefiore Medical Center
    Sep 15, 2021

    Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

    Completed
    Has Results
    • Anemia
    • +5 more
    • Denver, Colorado
    • +19 more
    Oct 20, 2022